Discovery of Tetracyclic Derivatives as Highly Potent, Selective, and Bioavailable PKMYT1 Inhibitors for Cancer Therapy
Year: 2025
Type: article
Source: Journal of Medicinal Chemistry
Institution: Simcere Pharmaceutical (China)
Language: English
Subfield: Computational Theory and Mathematics
Field: Computer Science
Domain: Physical Sciences
Open Access status: closed
OpenAlex ID: W7117574265
